BioSpace News Archive

The global venous skin ulcer treatment market was valued at US$ 2.6 Bn in 2022. It is expected to expand at a CAGR of ~5% during the forecast period from 2022 to 2030

The global vascular stents market is expected to reach ~US$ 12 Bn by the end of 2030, according to new report study.

Toronto, Ontario--(Newsfile Corp. - August 18, 2022) - ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) (“ScreenPro” or the “Company”) announces the voting results from the Annual General and Special Meeting of Shareholders (the “Meeting”) which was held on August 17, 2022.

According to Nova one advisor the global Acute Hospital Care market size was estimated at USD 2.10 trillion in 2021 and is expected to surpass around USD 4.10 trillion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 5.60% during the forecast period 2022 to 2030.

According to the current analysis of Reports and Data, the global Mycoplasma Testing market was valued at USD 609.39 Million in 2019 and is expected to reach USD 1.59 Billion by year 2027, at a CAGR of 12.6%.

According to the current analysis of Reports and Data, the global next generation sequencing market was valued at USD 5,793.4 million in 2019 and is expected to reach USD 22.16 billion by the year 2027, at a CAGR of 15.9%.

Kala Pharmaceuticals, Inc. announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly designated Series D Preferred Stock, par value $0.001 per share, for each outstanding share of the Company’s common stock held of record as of 5:00 p.m. Eastern Time on August 29, 2022.

Clarus Therapeutics Holdings, Inc. (Clarus) (Nasdaq:CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies, today reported financial results for the second quarter of 2022.

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced plans to present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually.

OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced the company will present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually.